Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
D-MANNOSE
ID: ALA469448
Max Phase: Phase
Molecular Formula: C6H12O6
Molecular Weight: 180.16
Molecule Type: Small molecule
Associated Items:
ID: ALA469448
Max Phase: Phase
Molecular Formula: C6H12O6
Molecular Weight: 180.16
Molecule Type: Small molecule
Associated Items:
Synonyms (4): Carubinose | D-mannose | Seminose | NSC-26247
Synonyms from Alternative Forms(4):
Canonical SMILES: OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6?/m1/s1
Standard InChI Key: WQZGKKKJIJFFOK-QTVWNMPRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 180.16 | Molecular Weight (Monoisotopic): 180.0634 | AlogP: -3.22 | #Rotatable Bonds: 1 |
Polar Surface Area: 110.38 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.30 | CX Basic pKa: | CX LogP: -2.93 | CX LogD: -2.93 |
Aromatic Rings: 0 | Heavy Atoms: 12 | QED Weighted: 0.29 | Np Likeness Score: 2.63 |
1. Anderson RA, Oswald C, Zaneveld LJ.. (1981) Inhibition of human acrosin by monosaccharides and related compounds: structure-activity relationships., 24 (11): [PMID:7031247] [10.1021/jm00143a005] |
2. Winkler DA, Holan G.. (1989) Design of potential anti-HIV agents. 1. Mannosidase inhibitors., 32 (9): [PMID:2504921] [10.1021/jm00129a011] |
3. Pei Z, Aastrup T, Anderson H, Ramström O.. (2005) Redox-responsive and calcium-dependent switching of glycosyldisulfide interactions with Concanavalin A., 15 (11): [PMID:15878660] [10.1016/j.bmcl.2005.04.024] |
4. Bhat N, Joe A, PereiraPerrin M, Ward HD.. (2007) Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro., 282 (48): [PMID:17905738] [10.1074/jbc.m706950200] |
5. Lairson LL, Watts AG, Wakarchuk WW, Withers SG.. (2006) Using substrate engineering to harness enzymatic promiscuity and expand biological catalysis., 2 (12): [PMID:17057723] [10.1038/nchembio828] |
6. Poláková M, Šesták S, Lattová E, Petruš L, Mucha J, Tvaroška I, Kóňa J.. (2011) α-D-mannose derivatives as models designed for selective inhibition of Golgi α-mannosidase II., 46 (3): [PMID:21295890] [10.1016/j.ejmech.2011.01.012] |
7. Euzen R, Reymond JL.. (2011) Synthesis of glycopeptide dendrimers, dimerization and affinity for Concanavalin A., 19 (9): [PMID:21481594] [10.1016/j.bmc.2011.03.047] |
8. PubChem BioAssay data set, |
9. PubChem BioAssay data set, |
10. Scharenberg M, Schwardt O, Rabbani S, Ernst B.. (2012) Target Selectivity of FimH Antagonists., 55 (22): [PMID:23088608] [10.1021/jm3010338] |
11. Unpublished dataset, |
12. Unpublished dataset, |
13. Unpublished dataset, |
14. Unpublished dataset, |
15. Unpublished dataset, |
16. Tomašić T, Hajšek D, Švajger U, Luzar J, Obermajer N, Petit-Haertlein I, Fieschi F, Anderluh M.. (2014) Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor., 75 [PMID:24556146] [10.1016/j.ejmech.2014.01.047] |
17. Tomasic T, Rabbani S, Gobec M, Rascan IM, Podlipnik C, Ernst B, Anderluh M. (2014) Branched -d-mannopyranosides: a new class of potent FimH antagonists, 5 (8): [10.1039/C4MD00093E] |
18. Beshr G, Sommer R, Hauck D, Siebert DCB, Hofmann A, Imberty A, Titz A. (2016) Development of a competitive binding assay for the Burkholderia cenocepacia lectin BC2L-A and structure activity relationship of natural and synthetic inhibitors, 7 (3): [10.1039/C5MD00557D] |
19. Bosco M, Massarweh A, Iatmanen-Harbi S, Bouhss A, Chantret I, Busca P, Moore SE, Gravier-Pelletier C.. (2017) Synthesis and biological evaluation of chemical tools for the study of Dolichol Linked Oligosaccharide Diphosphatase (DLODP)., 125 [PMID:27769035] [10.1016/j.ejmech.2016.10.013] |
20. Unpublished dataset, |
21. D'Ambrosio EA, Drake WR, Mashayekh S, Ukaegbu OI, Brown AR, Grimes CL.. (2019) Modulation of the NOD-like receptors NOD1 and NOD2: A chemist's perspective., 29 (10): [PMID:30890292] [10.1016/j.bmcl.2019.03.010] |
22. Sommer R, Rox K, Wagner S, Hauck D, Henrikus SS, Newsad S, Arnold T, Ryckmans T, Brönstrup M, Imberty A, Varrot A, Hartmann RW, Titz A.. (2019) Anti-biofilm Agents against Pseudomonas aeruginosa: A Structure-Activity Relationship Study of C-Glycosidic LecB Inhibitors., 62 (20): [PMID:31553873] [10.1021/acs.jmedchem.9b01120] |
23. (2014) Fibcd1 for the prevention and treatment of diseases, |
Source(5):